microRNA and epigenetic mechanism usually influence each other and evoke tumorigenesis in HCC. miR-376a was found dysregulated in HCC, while the underlying mechanism is elusive. Histone acetylation enzyme is known invoved in multiple microRNAs aberrations. In this study, we found that HDAC9 is a direct target of miR-376a. Interestingly, we found that HDAC9-mediated epigenetic modification resulted in miR-376 cluster dysregulation in HCC. In turn, decreased miR-376a partially resulted in up-regulation of HDAC9 in HCC. In sum, our results highlight the importance of feedback regulation in building epigenetic memory. Accumulating evidences have shown that microRNAs and epigenetic modifications are key factors in hepatocellular carcinoma (HCC) [1, 2] . Moreover, epigenetic and microRNA regulation are ususally interrelated [3, 4] . Specifically, microRNAs are involved in and controlled by epigenetic regulation, and therefore form a reciprocal regulatory circuit [5] [6] [7] [8] . It is interesting to discover HCC specific microRNAs and miRNA-related epigenetic modulations.
Accumulating evidences have shown that microRNAs and epigenetic modifications are key factors in hepatocellular carcinoma (HCC) [1, 2] . Moreover, epigenetic and microRNA regulation are ususally interrelated [3, 4] . Specifically, microRNAs are involved in and controlled by epigenetic regulation, and therefore form a reciprocal regulatory circuit [5] [6] [7] [8] . It is interesting to discover HCC specific microRNAs and miRNA-related epigenetic modulations.
Dlk1-Dio3 imprinted region, located in chromosome 14q32 [9] , is a cancer susceptibility locus and dysregulation of the miRNAs in this region has been found in liver tumors [10] . Moreover, it is the epigenetic modification that caused Dlk1-Dio3 microRNA cluster silence in various cancers, including epithelial ovarian cancer [11] and giant cell tumor of bone [12] . miR-376a, a member of Dlk1-Dio3 microRNA cluster, was frequently decreased in HCC and suppress proliferation of human hepatoma cells. Given miR-376a was located in Dlk1-Dio3 imprinted region, it is necessary to understand how miR-376a was influnced by epigenetic components and how they interact with each other.
Knowing that epigenetic modification of the Dlk1-Dio3 microRNA cluster is controlled by DNA methylation and histone acetylation at differentially methylated regions (DMRs) [13, 14] . Then, we detected the expression of miR-376a after the normal hepatic cell line (L02) and HCC cell line (Huh7) were treated with 5-aza-2′-deoxycytidine (5-Aza-CdR) and 4-phenyl-butyric acid (PBA), inhibitor of DNA methyltransferase and histone deacetylase, respectively. Moreover, we detected acetylation level of histone located in the Meg3 DMR by CHIP-PCR assays. Then, we confirmed that HDACi can induce the expression of miR-376 family by increasing the acetylation level of histone 3 at the Meg3 DMR.
Conversly, miRNAs play an important role in epigenetic modification by targeting epigenetic factors, with DNMTs and HDACs included. HDACs are enzymes involved in chromatin remodeling by deacetylating the lysine residues of
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histone, and play a pivotal role in epigenetic regulation [15] . Interestingly, histone deacetylasd 9 (HDAC9), a class II HDAC family member, was potential target of miR-376a, and we identified it by luciferase activity assays. Knowing that HDAC9 can increase the lysine acetylation of H3K9, H3K14 and H3K18 globally [16] , it is reasonable to assume that miR-376a may regulate the acetyl-histone H3K18 level (H3K9ac and H3K14ac can also be deacetylated by multiple HDACs, so we select H3K18 as the downstream effectors of HDAC9) by targeting HDAC9. Then, we examined the acetyl-histone H3K18 level in miR-376a treated Huh7 or L02 cells and found that miR-376a could induce global acetylation of histone H3K18 by targeting HDAC9.
As miR-376a was induced by HDACi, whether HDAC9 repress the expression of miR-376a? We knocked-down HDAC9 and detected miR-376a expression by qPCR. Moreover, the histone H3K18ac level at Meg3 DMR was detected by CHIP-PCR. We found that HDAC9 inhibited miR-376a by deacetylating histone H3K18 at Meg3 DMR. Finally, we determine the status of HDAC9 in HCC and found that HDAC9 is negatively correlated to miR-376a in HCC specimens. Thus, our data suggests that HDAC9-mediated epigenetic modification may contribute to the decrease of miR-376 cluster in HCC.
Having demonstrated that HDAC9 and miR-376a could inhibit each other, in other words, HDAC9 and miR-376a form a feed-forward loop in HCC. Feed forward regulation expands the set of possible biological properties and allows system to translated graded inputs to crucial outputs [17, 18] ; Therefore, this positive feedback loop may result in continuous decrease of miR-376a in HCC and selfreinforcing proliferation caused by miR-376a decrease.
As for the underlying mechanism of how miR-376a exert a tumor suppressor effect, we devoted ourselves to screen the most important target gene among the numerous candidate gene and identified it. Briefly, putative target genes were predicted using TargetScan and the pathway network of these candidate target genes were analyzed using Molecule Annotation System [19] . Interestingly, p85a was the hub of the network composed of the candidate target genes. Knowing that hub are central to biological activities and efficiently disturb the whole cellular function by destabilizing the network [19] [20] [21] , we identified that it was targeted by miR-376a. Moreover, p85a exert an oncogene effect and is inversly related to miR-376a in HCC. Our data suggested that decreased miR-376a promoted proliferation and inhibited apoptosis in HCC by targeting p85a.
In summary, HDAC9/miR-376a feed-forward loop provided signal amplification required for the establishment of tumorigenesis in hepatocellular carcinoma. Thus, it is presumable that this feedforward loop may play a role in the process of chronic inflammation to cancer initiation. Interrupting this feed-forward loop will arrest a proliferative phenotype.
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